Clarify Health Recognized for Innovation in Patient Recruitment in Clinical Trials

SAN FRANCISCO--(BUSINESS WIRE)-- For the third time this year, Clarify Health, a leading healthcare analytics platform company, is being honored by Frost & Sullivan. This award is for its innovation in accelerating patient recruitment in clinical trials. The 2022 North American Patient Recruitment IT Solutions New Product Innovation Award recognizes Clarify for its product, Clarify Trials, a real-world evidence (RWE) solution that enables life sciences companies—sponsors and Clinical Research Organizations (CROs)—to accelerate recruitment within underrepresented communities and niche patient populations to improve diversity, equity, and inclusion (DEI) in clinical trials.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221130005224/en/

(Graphic: Business Wire)

“To create a ground-breaking eClinical patient recruitment IT solution, a company must understand their unique market needs and deliver innovative products that can perform at a high-level and produce quality results,” said Unmesh Lal, Frost & Sullivan senior industry analyst in the healthcare sector. “After our rigorous review of the patient recruitment market, we found that Clarify Health embodies these concepts wholeheartedly.”

The Frost & Sullivan 2022 New Product Innovation Award report highlights several of the key distinctions of Clarify’s solution, including:

• Game-changing mapping of underrepresented communities that provide the most impactful insights to better meet recruitment goals and outperform competing solutions
• 15 billion government and commercial medical claim records and prescription drug data covering over 300 million unique lives with 400-plus SDoH factors in secure, Health Insurance Portability and Accountability Act (HIPAA)-compliant data lakes
• Unique software configuration that allows for precise inclusion and exclusion criteria
• Best-in-class return on investment (ROI) with most clients receiving a remarkable ROI in less than five months, and total investment recovery with just ten additional patients recruited

“Improving clinical trial diversity is an important step toward tackling undeniable disparities in healthcare,” said Clarify Health President Todd Gottula. “We are proud to be recognized by Frost & Sullivan for our achievements in empowering life sciences companies to use real-world data to recruit diverse and niche patient populations faster.”

Frost & Sullivan’s New Product Innovation Award recognizes those companies that offer new products or solutions that uniquely address key customer challenges. By analyzing a product’s match to needs, reliability, and quality, as well as customer impact in price, performance, and experience, Frost & Sullivan determines the best-in-class solutions across all sectors of the healthcare industry.

This is the fourth Frost & Sullivan recognition for Clarify Health. Earlier this year, Frost and Sullivan recognized Clarify Health for its innovations in the healthcare industry with the 2022 North American Customer Value Leadership Award for the company’s value-based care platform. Clarify Health is also the recipient of Frost & Sullivan’s 2021 New Product Innovation Award in the Life Sciences Industry for its RWE solutions. Clarify was also recently included in the Frost Radar™: Healthcare Data Analytics 2022 Report, receiving the highest score on the Frost Radar^TM Innovation Index.

Access the full Frost & Sullivan 2022 North American Patient Recruitment IT Solutions New Product Innovation Award Report here.

About Clarify Health

Clarify Health is an enterprise analytics and value-based payments platform company that empowers payers, providers, and life sciences companies to deliver better care, therapies, and outcomes with actionable patient journey insights. Clarify’s cloud-based business applications are built on the Clarify Atlas Platform, which maps 300M+ patient journeys to deliver 18B+ AI-powered predictions and surface insights with speed and precision. Clarify’s products illuminate actionable opportunities to drive growth, optimize networks, improve care delivery, manage population health, maximize value-based care performance, and bring therapies to market. With Clarify, healthcare organizations can leapfrog from point-solution and manual analytics to self-service, rapid generation of enterprise insights that light the path to better care and outcomes. Learn more at clarifyhealth.com.

About Frost & Sullivan

Frost & Sullivan is the Growth Pipeline Company™. We power our clients to a future shaped by growth. Our Growth Pipeline as a Service™ provides the CEO and the CEO’s growth team with a continuous and rigorous platform of growth opportunities, ensuring long-term success. To achieve positive outcomes, our team leverages over 60 years of experience, coaching organizations of all types and sizes across 6 continents with our proven best practices. To power your Growth Pipeline future, visit Frost & Sullivan at http://www.frost.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20221130005224/en/